Who is sponsoring NCT03766152?

NCT03766152 is sponsored by Dominik Riss.

What drugs are being tested in NCT03766152?

Interventions in NCT03766152: Adhesive bone conduction hearing aid (ADHEAR - Med El).

What condition does NCT03766152 study?

NCT03766152 studies Bone Conduction Deafness, Hearing Loss, Conductive.

Is NCT03766152 still recruiting?

NCT03766152 is currently completed. Last updated 2 January 2020.

Last reviewed 2020-01-02 · How we verify

NCT03766152

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Audiological Benefit and Improved Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Bonebridge in Experienced Users

Completed NA Last updated 2 January 2020

What this trial tests

NA trial testing Adhesive bone conduction hearing aid (ADHEAR - Med El) in Bone Conduction Deafness in 19 participants. Completed in 13 December 2019.

Timeline

1 November 2018

Primary endpoint
31 October 2019

13 December 2019

Quick facts

Lead sponsor	Dominik Riss
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	19
Start date	1 November 2018
Primary completion	31 October 2019
Estimated completion	13 December 2019
Sites	1 location across Austria

Drugs / interventions tested

Adhesive bone conduction hearing aid (ADHEAR - Med El)

Conditions studied

Bone Conduction Deafness — all drugs for Bone Conduction Deafness →
Hearing Loss, Conductive — all drugs for Hearing Loss, Conductive →

Sponsor

Dominik Riss

Who can join

Adults 13 to 99, any sex, with Bone Conduction Deafness or Hearing Loss, Conductive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Patients implanted with a Bonebridge will be asked to be part of the study. The study subjects are enrolled into the study according to inclusion criteria. Patients will be asked to wear an adhesive bone conduction device an adapt to it for 30-60 min. After this time period patients will be asked to use the adhesive device instead of the Bonebridge for 3 weeks. Audiologic Tests and quality of life questionnaires will be assessed at the beginning of the study and at the end of three weeks.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bone Conduction Deafness

Currently open trials in the same condition.

NCT06039332 — Subjective and Audiological Benefit of BONEBRIDGE (BCI602) With Two Different Fitting Strategies · NA · recruiting

Other Dominik Riss trials

Trials by the same sponsor.

NCT03746548 — Audiological Benefit and Quality of Life With Two Bone Conduction Systems: ADHEAR vs. Contact Mini · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03766152 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dominik Riss
Last refreshed: 2 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03766152.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing